Weis Markets Reports Q4 Revenue of $1.29B
Reports Q4 revenue $1.29B vs. $1.23B last year. "Despite ongoing cautious customer spending, our Company achieved strong year-over-year sales growth, supported by significant price investments and record capital expenditures that enabled five new store openings and seven major remodels. We also delivered a 21% increase in e-commerce sales while benefitting from elevated pharmacy volume following a competitor's market exit," said Weis Markets, Inc. Chairman, President, and CEO Jonathan H. Weis. "In 2025, long-term investing remained a priority as we continued to support our future growth. Our store, supply chain and support associates helped us improve efficiencies and incorporate technologies that promote a superior customer experience. We are proud of our associates and grateful for their many contributions."
Trade with 70% Backtested Accuracy
Analyst Views on WMK
About WMK
About the author

- Financial Restatement Announcement: On February 26, 2026, Weis Markets disclosed to the SEC that its audited financial statements for fiscal years 2022 to 2024 and interim statements for 2025 will be restated due to inaccurately recorded and overstated inventory, raising significant investor concerns.
- Stock Price Reaction: Following the announcement, Weis Markets' stock price fell by $5.12, a decline of 7.16%, closing at $66.39 per share, reflecting market apprehension regarding the company's financial transparency and potential legal risks.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Weis Markets and its executives engaged in securities fraud or other unlawful business practices, with investors advised to contact the firm to join the class action, potentially exposing the company to greater legal liabilities.
- Annual Report Delay: Weis Markets announced a delay in filing its 2025 Annual Report until the review and restatement process is completed, which may undermine investor confidence in the company's future financial health.
- Financial Restatement Announcement: Weis Markets disclosed in a Form 8-K on February 26, 2026, that its audited financial statements for fiscal years 2022 through 2024 will be restated due to inaccurately recorded and overstated inventory, which could undermine investor confidence and lead to stock price volatility.
- Stock Price Decline Impact: Following the restatement announcement, Weis Markets' shares fell by $5.12, or approximately 7.16%, from $71.51 on February 25, 2026, to close at $66.39, reflecting market concerns over the company's financial transparency.
- Ongoing Investigation: No lawsuit has been filed against Weis Markets yet, but an investigation into potential violations of federal securities laws is underway, which could result in future legal liabilities and financial repercussions for the company.
- Investor Rights Protection: Investors with information or those wishing to learn more about the investigation can contact Kirby McInerney LLP to discuss their rights, indicating the firm's commitment to protecting investor interests.
- Financial Restatement Announcement: On February 26, 2026, Weis Markets disclosed to the SEC that its audited financial statements for fiscal years 2022 through 2024 and interim statements for 2025 will be restated due to inaccurately recorded and overstated inventory, which will impact the company's financial transparency and investor confidence.
- Significant Stock Price Drop: Following the restatement announcement, Weis Markets' stock price fell by $5.12, or 7.16%, closing at $66.39, indicating market concerns over the company's financial health and potentially leading to pessimistic expectations regarding future performance.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Weis Markets and its executives have engaged in securities fraud or other unlawful business practices, which could expose the company to legal liabilities and further damage its market reputation and shareholder interests.
- Annual Report Filing Delay: Weis Markets announced a delay in filing its 2025 Annual Report until the review and restatement process is completed, which may undermine investor trust in the company's governance and financial stability, increasing market uncertainty.
- Financial Restatement Announcement: Weis Markets disclosed on February 26, 2026, via an 8-K filing that due to inaccurately recorded and overstated inventory, audited financial statements for fiscal years 2022 through 2024 and interim financial statements for 2025 will be restated, which could significantly impact investor confidence.
- Delayed Annual Report Filing: The company announced it would delay the filing of its 2025 Form 10-K until the review and restatement process is completed, raising concerns about the company's transparency and potentially affecting its stock performance.
- Significant Stock Price Decline: Following the restatement news, Weis Markets' stock price dropped by $5.12, or approximately 7.16%, from $71.51 on February 25, 2026, to close at $66.39, reflecting market concerns regarding the company's financial health.
- Legal Investigation Initiated: The prominent law firm Lowey Dannenberg is investigating Weis Markets for potential violations of federal securities laws, and investors who suffered losses in the company's securities may face the risk of collective lawsuits, further exacerbating market uncertainty.
- Financial Restatement Announcement: Weis Markets disclosed on February 26, 2026, via an 8-K filing that its audited financial statements for fiscal years 2022 to 2024 will be restated due to inaccurately recorded inventory, which could undermine investor confidence and lead to stock price volatility.
- Stock Price Decline: Following the announcement, Weis Markets' shares fell by $5.12, or approximately 7.16%, from $71.51 on February 25, 2026, to close at $66.39, indicating market concerns regarding the company's financial transparency.
- Ongoing Investigation: No lawsuits have been filed yet, but Kirby McInerney LLP is conducting an investigation to determine if there are grounds for claims under federal securities laws, which could result in future legal liabilities for the company.
- Investor Rights Protection: Kirby McInerney LLP encourages all investors who purchased Weis Markets securities to contact them to understand their rights and interests, demonstrating the firm's proactive stance in protecting investor interests.
- Financial Restatement Announcement: On February 26, 2026, Weis Markets disclosed to the SEC that its audited financial statements for fiscal years 2022 through 2024 and interim statements for 2025 will be restated due to inaccurately recorded and overstated inventory, which could significantly impact investor confidence.
- Stock Price Plunge: Following the financial restatement news, Weis Markets' stock price fell by $5.12, or 7.16%, closing at $66.39, reflecting market concerns over the company's financial health and potentially leading to investor losses.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Weis Markets and certain officers have engaged in securities fraud or other unlawful business practices, with investors advised to contact the firm to join the class action, which could expose the company to legal liabilities and compensation risks.
- Annual Report Delay: Weis Markets announced a delay in filing its 2025 Annual Report until the review and restatement process is completed, which may affect the company's transparency and investors' expectations regarding its future performance.










